Jeff Yass’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
Other funds holding IKT
SL
Jeff Yass's IKT Position: Q3 2026 in Review
Jeff Yass reduced its Inhibikase Therapeutics (IKT) stake by 20% in Q3 2026, selling an estimated $7.39K and leaving 12,996 shares worth $26.7K. The position accounts for ﹤0.01% of the portfolio, ranked #13062.
Jeff Yass first reported a position in IKT in Q1 2022 and has held it in 10 quarters since. The position peaked at $1.11M in Q1 2025. 110 funds tracked by Wall St. Rank hold IKT as of Q3 2026.
- Jeff Yass held 12,996 shares of Inhibikase Therapeutics worth $26.7K as of Q3 2026.
- Jeff Yass sold 3,246 Inhibikase Therapeutics shares in Q3 2026, an estimated $7.39K.
- Inhibikase Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13062 holding.
- Jeff Yass first reported a position in Inhibikase Therapeutics in Q1 2022 and has held it in 10 quarters since.
- Jeff Yass's Inhibikase Therapeutics position peaked at $1.11M in Q1 2025.
- 110 funds tracked by Wall St. Rank held Inhibikase Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.